RPG Life Sciences received setback during the second quarter ended September 2006 despite lower interest and depreciation provisions. Its net profit dwindled to Rs 3.06 crore from Rs 5.97 crore in the corresponding period of last year, a fall of 48.7 per cent. The net sales also declined by 7.6 per cent to Rs 33.45 crore from Rs 36.22 crore in the last period. With the fall in profits, its EPS nose-dived to Rs 2.13 from Rs 4.80.

For the first six months period ended September 2006, its net profit declined by 48.6 per cent to Rs 6.43 crore from Rs 12.52 crore in the similar six months of last year. Its net sales came down heavily by 20.4 per cent to Rs 63.58 crore from Rs 79.84 crore. The company has provided for the liability arising out of termination of lease arrangement with Hindustan Antibiotics Ltd for its plant and equipment at Pune. It has to make further provision of Rs 1.62 crore for termination of this agreement.

The company recorded net sales of Rs 144.30 crore and earned a net profit of Rs 19.68 crore during the year ended March 2006.